Amelioration of cisplatin-induced mouse renal lesions by a cyclooxygenase (COX)-2 selective inhibitor

European Journal of Pharmacology

Volumn 715, Issue 1-3, 2013, Pages 181-188

  Honma, Shigeyoshi ^a   Takahashi, Naho ^a   Shinohara, Masahiro ^a   Nakamura, Kazuki ^a   Mitazaki, Satoru ^a   Abe, Sumiko ^a   Yoshida, Makoto ^a  

^a TAKASAKI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Cisplatin; COX 2 selective inhibitor; Inflammation; Oxidative stress; Renal lesions

Indexed keywords

4 HYDROXYNONENAL; CISPLATIN; CREATININE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GLUCOSE; HEME OXYGENASE 1; MELOXICAM; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NITROGEN; PROSTAGLANDIN E2; PROTEIN P47; PROTEIN P67; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; STRESS ACTIVATED PROTEIN KINASE; THROMBOXANE B2; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GENE EXPRESSION; GLUCOSE URINE LEVEL; MACROPHAGE; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UREA NITROGEN BLOOD LEVEL;

CISPLATIN; COX-2 SELECTIVE INHIBITOR; INFLAMMATION; OXIDATIVE STRESS; RENAL LESIONS;

ANIMALS; CISPLATIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; KIDNEY; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; OXIDATIVE STRESS; THIAZINES; THIAZOLES; THROMBOXANE B2;

EID: 84885471329     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.05.023     Document Type: Article

References (48)

1. Chakraborty, P., Roy, S.S., Sk, U.H., Bhattacharya, S., 2011. Amelioration of cisplatin-induced nephrotoxicity in mice by oral administration of diphenylmethyl selenocyanate. Free Radic. Res. 45, 177-187.
2. Chirino, Y.I., Sanchez-Gonzalez, D.J., Martinez-Martinez, C.M., Cruz, C., Pedraza-Chaverri, J., 2008. Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology 245, 18-23.
3. Ciarimboli, G., Ludwig, T., Lang, D., Pavenstadt, H., Koepsell, H., Piechota, H.J., Haier, J., Jaehde, U., Zisowsky, J., Schlatter, E., 2005. Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. Am. J. Pathol. 167, 1477-1484. (Pubitemid 41713303)
4. Cogolludo, A., Frazziano, G., Cobeño, L., Moreno, L., Lodi, F., Villamor, E., Tamargo, J., Perez-Vizcaino, F., 2006. Role of reactive oxygen species in Kv channel inhibition and vasoconstriction induced by TP receptor activation in rat pulmonary arteries. Ann. N Y Acad. Sci. 1091, 41-51. (Pubitemid 47092223)
5. Cornelison, T.L., Reed, E., 1993. Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin. Gynecol. Oncol. 50, 147-158. (Pubitemid 23275196)
6. Day, Y.J., Huang, L., Ye, H., Linden, J., Okusa, M.D., 2005. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am. J. Physiol. Renal Physiol. 288, F722-731. (Pubitemid 40381739)
7. De Greef, K.E., Ysebaert, D.K., Dauwe, S., Persy, V., Vercauteren, S.R., Mey, D., De Broe, M.E., 2001. Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int. 60, 1415-1427. (Pubitemid 32960035)
8. Feitoza, C.Q., Camara, N.O., Pinheiro, H.S., Goncalves, G.M., Cenedeze, M.A., Pacheco-Silva, A., Santos, O.F., 2005. Cyclooxygenase 1 and/or 2 blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion injury. Int Immu-nopharmacol. 5, 79-84. (Pubitemid 39626687)
9. Fram, R.J., 1992. Cisplatin and platinum analogues: recent advances. Curr. Opin. Oncol. 4, 1073-1079.
10. Francescato, H.D., Costa, R.S., Junior, F.B., Coimbra, T.M., 2007. Effect of JNK inhibition on cisplatin-induced renal damage. Nephrol. Dial. Transplant. 22, 2138-2148. (Pubitemid 47244690)
11. Ge, Y., Strait, KA., Stricklett, P.K., Yang, T., Kohan, DE., 2007. Role of prostaglandins in collecting duct-derived endothelin-1 regulation of blood pressure and water excretion. Am. J. Physiol. Renal Physiol. 293, F1805-1810. (Pubitemid 350179605)
12. Harris, R.C., 2000. Cyclooxygenase-2 in the kidney. J. Am. Soc. Nephrol. 11, 2387-2394.
13. Honma, S., Saika, M., Ohkubo, S., Kurose, H., Nakahata, N., 2006. Thromboxane A2 receptor-mediated G12/13-dependent glial morphological change. Eur. J. Pharmacol. 545, 100-108. (Pubitemid 44262350)
14. Jia, Z., Wang, N., Aoyagi, T., Wang, H., Liu, H., Yang, T., 2011. Amelioration ofcisplatin nephrotoxicity by genetic or pharmacologic blockade of prostaglandin synthesis. Kidney Int. 79, 77-88.
15. Jin, L., Beswick, R.A., Yamamoto, T., Palmer, T., Taylor, T.A., Pollock, J.S., Pollock, D.M., Brands, M.W., Webb, R.C., 2006. Increased reactive oxygen species contributes to kidney injury in mineralocorticoid hypertensive rats. J. Physiol. Pharmacol. 57, 343-357. (Pubitemid 44543871)
16. Jo, S.K., Cho, W.Y., Sung, S.A., Kim, H.K., Won, N.H., 2005. MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney Int. 67, 458-466. (Pubitemid 40139837)
17. Jo, S.K., Sung, S.A., Cho, W.Y., Go, K.J., Kim, H.K., 2006. Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol. Dial. Transplant. 21, 1231-1239.
18. Kanayama, M., Yamaguchi, S., Shibata, T., Shibata, N., Kobayashi, M., Nagai, R., Arai, H., Takahashi, K., Uchida, K., 2007. Identification of a serum component that regulates cyclooxygenase-2 gene expression in cooperation with 4-hydroxy-2-nonenal. J. Biol. Chem. 282, 24166-24174. (Pubitemid 47328025)
19. Khan, K.N., Venturini, C.M., Bunch, R.T., Brassard, J.A., Koki, A.T., Morris, D.L., Trump, B.F., Maziasz, T.J., Alden, C.L., 1998. Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity. Toxicol. Pathol. 26, 612-620. (Pubitemid 28462712)
20. Kim, J., Seok, Y.M., Jung, K.J., Park, K.M., 2009. Reactive oxygen species/oxidative stress contributes to progression of kidney fibrosis following transient ischemic injury in mice. Am. J. Physiol. Renal Physiol. 297, F461-470.
21. Kim, J.H., Yang, J.I., Jung, M.H., Hwa, J.S., Kang, K.R., Park, D.J., Roh, G.S., Cho, G.J., Choi, W.S., Chang, S.H., 2006. Heme oxygenase-1 protects rat kidney from ureteral obstruction via an antiapoptotic pathway. J. Am. Soc. Nephrol. 17, 1373-1381. (Pubitemid 43673417)
22. Kohda, Y., Kawai, Y., Iwamoto, N., Matsunaga, Y., Aiga, H., Awaya, A., Gemba, M., 2005. Serum thymic factor, FTS, attenuates cisplatin nephrotoxicity by suppressing cisplatin-induced ERK activation. Biochem. Pharmacol. 70, 1408-1416. (Pubitemid 41383477)
23. Kumagai, T., Matsukawa, N., Kaneko, Y., Kusumi, Y., Mitsumata, M., Uchida, K., 2004. A lipid peroxidation-derived inflammatory mediator: identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. J. Biol. Chem. 279, 48389-48396. (Pubitemid 39540995)
24. Lameire, N., Van Biesen, W., Vanholder, R., 2005. Acute renal failure. Lancet 365, 417-430. (Pubitemid 40179230)
25. Lee, S., Kim, W., Moon, S.O., Sung, M.J., Kim, D.H., Kang, K.P., Jang, Y.B., Lee, J.E., Jang, K.Y., Park, S.K., 2006a. Rosiglitazone ameliorates cisplatin-induced renal injury in mice. Nephrol. Dial. Transplant. 21, 2096-2105. (Pubitemid 44295034)
26. Lee, S., Moon, S.O., Kim, W., Sung, M.J., Kim, D.H., Kang, K.P., Jang, Y.B., Lee, J.E., Jang, K.Y., Lee, S.Y., Park, S.K., 2006b. Protective role of L-2-oxothiazolidine-4-carboxylic acid in cisplatin-induced renal injury. Nephrol. Dial. Transplant. 21, 2085-2095. (Pubitemid 44295033)
27. Luo, J., Tsuji, T., Yasuda, H., Sun, Y., Fujigaki, Y., Hishida, A., 2008. The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrol. Dial. Transplant. 23, 2198-2205. (Pubitemid 351957613)
28. Matsushima, H., Yonemura, K., Ohishi, K., Hishida, A., 1998. The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J. Lab Clin. Med. 131, 518-526. (Pubitemid 28278570)
29. Mitazaki, S., Kato, N., Suto, M., Hiraiwa, K., Abe, S., 2009. Interleukin-6 deficiency accelerates cisplatin-induced acute renal failure but not systemic injury. Toxicology 265, 115-121.
30. Ouyang, X., Le, T.H., Roncal, C., Gersch, C., Herrera-Acosta, J., Rodriguez-Iturbe, B., Coffman, T.M., Johnson, R.J., Mu, W., 2005. Th1 inflammatory response with altered expression of profibrotic and vasoactive mediators in AT1A and AT1B double-knockout mice. Am. J. Physiol. Renal Physiol. 289, F902-910. (Pubitemid 41324211)
31. Pan, H., Mukhopadhyay, P., Rajesh, M., Patel, V., Mukhopadhyay, B., Gao, B., Hasko, G., Pacher, P., 2009. Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death. J. Pharmacol. Exp. Ther. 328, 708-714.
32. Patel, N.S., Cuzzocrea, S., Collino, M., Chaterjee, P.K., Mazzon, E., Britti, D., and Yaqoob., M. M., Thiemermann, C., 2007. The role of cycloxygenase-2 in the rodent kidney following ischaemia/reperfusion injury in vivo. Eur. J. Pharmacol. 562, 148-154. (Pubitemid 46466766)
33. Polk, W.W., Ellis, M.E., Kushleika, J.V., Simmonds, P.L., Woods, J.S., 2007. RhoA regulation of NF-kappaB activation is mediated by COX-2-dependent feedback inhibition of IKK in kidney epithelial cells. Am. J. Physiol. Cell Physiol. 293, C1160-1170. (Pubitemid 47437390)
34. Ramachandiran, S., Huang, Q., Dong, J., Lau, S.S., Monks, T.J., 2002. Mitogen-activated protein kinases contribute to reactive oxygen species-induced cell death in renal proximal tubule epithelial cells. Chem. Res. Toxicol. 15, 1635-1642. (Pubitemid 36008212)
35. Ramesh, G., Reeves, W.B., 2002. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J. Clin. Invest. 110, 835-842.
36. Sheikh-Hamad, D., Cacini, W., Buckley, A.R., Isaac, J., Truong, L.D., Tsao, C.C., Kishore, B.K., 2004. Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney. Arch. Toxicol. 78, 147-155. (Pubitemid 38657196)
37. Sheppard, F.R., Kelher, M.R., Moore, E.E., McLaughlin, N.J., Banerjee, A., Silliman, C.C., 2005. Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation. J. Leukoc. Biol. 78, 1025-1042. (Pubitemid 41572466)
38. Stocker, R., Yamamoto, Y., McDonagh, A.F., Glazer, A.N., Ames, B.N., 1987. Bilirubin is an antioxidant of possible physiological importance. Science 235, 1043-1046. (Pubitemid 17049750)
39. Sue, Y.M., Cheng, C.F., Chou, Y., Chang, C.C., Lee, P.S., Juan, S.H., 2011. Ectopic overexpression of haem oxygenase-1 protects kidneys from carboplatin-mediated apoptosis. Br. J. Pharmacol. 162, 1716-1730.
40. Sugiyama, H., Kobayashi, M., Wang, D.H., Sunami, R., Maeshima, Y., Yamasaki, Y., Masuoka, N., Kira, S., Makino, H., 2005. Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice. Nephrol. Dial. Transplant. 20, 2670-2680. (Pubitemid 41672265)
41. Tusgaard, B., Norregaard, R., Jensen, A.M., Wang, G., Topcu, S.O., Wang, Y., Nielsen, S., Frokiaer, J., 2011. Cisplatin decreases renal cyclooxygenase-2 expression and activity in rats. Acta Physiol. (Oxf) 202, 79-90.
42. Usatyuk, P.V., Natarajan, V., 2004. Role of mitogen-activated protein kinases in 4-hydroxy-2-nonenal-induced actin remodeling and barrier function in endothelial cells. J. Biol. Chem. 279, 11789-11797. (Pubitemid 38401684)
43. Vesely, P.W., Staber, P.B., Hoefler, G., Kenner, L., 2009. Translational regulation mechanisms of AP-1 proteins. Mutat. Res. 682, 7-12.
44. Wagener, F.A., Dekker, D., Berden, J.H., Scharstuhl, A., van der Vlag, J., 2009. The role of reactive oxygen species in apoptosis of the diabetic kidney. Apoptosis 14, 1451-1458.
45. Wei, Q., Dong, G., Franklin, J., Dong, Z., 2007. The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int. 72, 53-62. (Pubitemid 47014446)
46. Yamaguchi, K., Ishikawa, T., Kondo, Y., Fujisawa, M., 2008. Cisplatin regulates Sertoli cell expression of transferrin and interleukins. Mol. Cell. Endocrinol. 283, 68-75.
47. Yamamato, E., Izawa, T., Sawamoto, O., Juniantito, V., Kuwamura, M., Yamate, J., 2011. Amelioration of cisplatin-induced rat renal lesions by a cyclooxygenase (COX)-2 selective inhibitor. Exp. Toxicol. Pathol. 64, 625-631.
48. Zarrouki, B., Soares, A.F., Guichardant, M., Lagarde, M., Geloen, A., 2007. The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell. FEBS Lett. 581, 2394-2400. (Pubitemid 46764695)